[Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin].
Rodríguez
J N
JN
Prados
D
D
Martino
M L
ML
Muñiz
R
R
D000368:Aged; D000753:Anemia, Refractory / Q000097:blood / Q000628:therapy*; D000756:Anemia, Sideroblastic / Q000097:blood / Q000628:therapy; D002648:Child; D004341:Drug Evaluation; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D007155:Immunologic Factors; D011994:Recombinant Proteins; D004921:Erythropoietin
Tratamiento de la anemia de síndromes mielodisplásicos con eritropoyetina recombinante humana.